Thyroid cancer cases soar; is it overdiagnosed?

February 22, 2014 by Lindsey Tanner

A dramatic rise in thyroid cancer has resulted from overdiagnosis and treatment of tumors too small to ever cause harm, according to a study that found cases nearly tripled since 1975.

The study is the latest to question whether all cancers need aggressive treatment. Other research has suggested that certain cancers of the prostate, breast and lung as well as thyroid grow so slowly that they will never become deadly, and that overzealous screening leads to overtreatment.

The thyroid is a hormone-releasing gland in the neck that helps regulate the body's metabolism. Thyroid cancer treatment often includes surgery to remove the butterfly-shaped gland, followed by lifelong daily hormone pills.

Thyroid removal is done for 85 percent of all people diagnosed despite guidelines that say less aggressive surgery is reasonable for lower-risk thyroid tumors, the study authors said.

"Our old strategy of looking as hard as possible to find cancer has some real side effects," said Dr. Gilbert Welch, co-author of the thyroid study and a professor of medicine at the Dartmouth Institute for Health Policy and Clinical Practice.

Welch said patients "can no longer assume" that labeling a disease as cancer means treatment is necessary. "It's a challenging rethinking," he added.

Welch and Dartmouth colleague Dr. Louise Davies analyzed government data from 1975 to 2009 and found thyroid cancers jumped from 5 cases per 100,000 people to 14 per 100,000. Most of that increase was in papillary thyroid cancers, the most common and least deadly kind; those cases jumped from about three cases per 100,000 to more than 12 per 100,000.

The results suggest there is "an ongoing epidemic of thyroid cancer" nationwide, they said.

The study was published online Thursday in JAMA Otolaryngology.

Despite the increase, thyroid cancer is relatively uncommon; more than 60,000 cases were diagnosed nationwide last year, according to the American Cancer Society. Risk factors for include diets low in iodine - rare in the United States - and radiation exposure. Women are more commonly diagnosed than men.

The new research echoes previous studies but "certainly raises some provocative questions," said Dr. Brian Burkey, a Cleveland Clinic head and neck cancer specialist.

Experts know that better detection methods including CT scans and ultrasound, have led to more thyroid cancers being diagnosed, but they don't know which ones will become aggressive, Burkey said.

"Thyroid cancer even if treated has a fairly high recurrence rate even if it doesn't kill," he said.

Burkey is among researchers planning a major study seeking to provide answers. Patients diagnosed with thyroid cancers will be randomly assigned treatment or just observation.

In the meantime, the study authors offer some advice: Physicians could "openly share with patients the uncertainty surrounding small thyroid cancers - explaining that many will never grow and cause harm to a patient," but that it's not possible to know for certain which ones are harmless.

That would allow patients to make better informed decisions, and some might opt for close monitoring instead of treatment, the authors said.

Explore further: Thyroid cancer cases double in 20 years, report finds

More information: JAMA Otolaryngology: jamaotolaryngology.com

Thyroid cancer: tinyurl.com/keezr69

Related Stories

Thyroid cancer cases double in 20 years, report finds

December 14, 2012
The number of people diagnosed with thyroid cancer in England has doubled since the early 1990s, according to a new report published by the National Cancer Intelligence Network (NCIN) today (Friday).

High-tech imaging contributing to overdiagnosis of low-risk thyroid cancers

August 27, 2013
An increasing gap between the incidence of thyroid cancer and deaths from the disease suggests that low-risk cancers are being overdiagnosed and overtreated, a study from the Mayo Clinic Center for the Science of Health Care ...

Genetic factors behind radiation-induced thyroid cancer

December 4, 2013
Scientists have long sought to determine whether heredity is one of the factors responsible for increased risk of thyroid cancer, but their results have been inconclusive... until now.

Nexavar approval expanded for common thyroid cancer

November 24, 2013
(HealthDay)—U.S. Food and Drug Administration approval for the anti-cancer drug Nexavar (sorafenib) has been expanded to include late-stage differentiated thyroid cancer, the most common type of thyroid cancer.

The Medical Minute: Thyroid cancer on the rise

September 21, 2012
September is Thyroid Cancer Awareness Month. With cases on the rise locally, nationally and globally, Dr. David Goldenberg, director of Head and Neck Surgery at Penn State Hershey Medical Center, hopes people will become ...

Steady rise in thyroid cancer not explained by better screening, study says

October 10, 2013
(HealthDay)—Better detection alone doesn't explain the dramatic increase in thyroid cancer cases seen in the United States over the past three decades, a new study says.

Recommended for you

Single blood test screens for eight cancer types

January 18, 2018
Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

Researchers find a way to 'starve' cancer

January 18, 2018
Researchers at Vanderbilt University Medical Center (VUMC) have demonstrated for the first time that it is possible to starve a tumor and stop its growth with a newly discovered small compound that blocks uptake of the vital ...

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.